Trigyceride mg/dL · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
HDL‐cholesterol · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
White population, normotensive, DBP mmHg · White population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
LDL‐cholesterol · Participants with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
White population, hypertensive, SBP mmHg · White population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
White population, hypertensive, DBP mmHg · White population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Black population, normotensive, SBP mmHg · Black population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Black population, normotensive, DBP mmHg · Black population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Black population, hypertensive, SBP mmHg · Black population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Black population, hypertensive, DBP mmHg · Black population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
Asian population, normotensive, SBP mmHg · Asian population with normal or elevated blood pressure, but otherwise healthy
1 finding from 1 review
FVC · adults, children and young people with CF
1 finding from 1 review
Lung function: FEF25‐75 mL/s (change from baseline) · adults, children and young people with CF
1 finding from 1 review
Adverse events relating to treatment Scale: mild, moderate, severe and total · adults, children and young people with CF
1 finding from 1 review
HRQoL ‐ change from baseline in CFCS total score and CFQ‐R respiratory domain · children and young adults with CF
1 finding from 1 review
FEV1 · children and young adults with CF
The review found no eligible studies for this question.
1 finding from 1 review
FEV1 % predicted: absolute change from baseline · children and young adults with CF
1 finding from 1 review
FVC (% predicted) Change from baseline · children and young adults with CF
1 finding from 1 review
Lung function: FEF25‐75 mL/s (percentage change from baseline) · children and young adults with CF
1 finding from 1 review
Adverse events relating to treatment Scale: mild, moderate, severe and total · children and young adults with CF
1 finding from 1 review